LC-280126

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLC-280126
Drug Alias NameLC-280126NecroX-7LC28-0126MIT-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsST Elevation Myocardial InfarctionStomatitisHematologic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMitoImmune Therapeutics Inc
Inactive CompaniesLg Chemical Ltd
Active IndicationsStomatitisHematologic NeoplasmsMultiple Myeloma +[5] 
Inactive IndicationsST Elevation Myocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A